Actively Recruiting
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Led by Brigham and Women's Hospital · Updated on 2024-08-22
4000
Participants Needed
3
Research Sites
1565 weeks
Total Duration
On this page
Sponsors
B
Brigham and Women's Hospital
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.
CONDITIONS
Official Title
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Undergoing heart surgery
- Willing to provide consent
You will not qualify if you...
- Enrolled in a concurrent drug or device trial that precludes concurrent enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
Completed
2
UT Southwestern Medical Center
Dallas, Texas, United States, 75390-9068
Actively Recruiting
3
Department Texas Heart Institute at St. Luke's Episcopal Hospital
Houston, Texas, United States, 77225
Completed
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here